IL258828A - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer - Google Patents
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerInfo
- Publication number
- IL258828A IL258828A IL258828A IL25882818A IL258828A IL 258828 A IL258828 A IL 258828A IL 258828 A IL258828 A IL 258828A IL 25882818 A IL25882818 A IL 25882818A IL 258828 A IL258828 A IL 258828A
- Authority
- IL
- Israel
- Prior art keywords
- quinolin
- imidazo
- cancer therapy
- ion compounds
- ion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1519568.8A GB201519568D0 (en) | 2015-11-05 | 2015-11-05 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| PCT/EP2016/076416 WO2017076898A1 (en) | 2015-11-05 | 2016-11-02 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL258828A true IL258828A (en) | 2018-06-28 |
Family
ID=55132360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL258828A IL258828A (en) | 2015-11-05 | 2018-04-22 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20180280377A1 (https=) |
| EP (1) | EP3370722A1 (https=) |
| JP (1) | JP2019501873A (https=) |
| KR (1) | KR20180073684A (https=) |
| CN (1) | CN108348515A (https=) |
| AU (1) | AU2016348620B2 (https=) |
| BR (1) | BR112018007811A2 (https=) |
| CA (1) | CA3002717A1 (https=) |
| CL (1) | CL2018001171A1 (https=) |
| CO (1) | CO2018004933A2 (https=) |
| CR (1) | CR20180308A (https=) |
| DO (1) | DOP2018000115A (https=) |
| GB (1) | GB201519568D0 (https=) |
| HK (1) | HK1257677A1 (https=) |
| IL (1) | IL258828A (https=) |
| MX (1) | MX2018004954A (https=) |
| NI (1) | NI201800051A (https=) |
| PE (1) | PE20181346A1 (https=) |
| PH (1) | PH12018500957A1 (https=) |
| RU (1) | RU2018120492A (https=) |
| SV (1) | SV2018005680A (https=) |
| WO (1) | WO2017076898A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| WO2019057757A1 (en) | 2017-09-20 | 2019-03-28 | Astrazeneca Ab | 1,3-DIHYDROIMIDAZO [4,5-C] CINNOLIN-2-ONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER |
| CN110386932A (zh) * | 2018-04-20 | 2019-10-29 | 艾科思莱德制药公司 | 用于抗肿瘤疗法中的双重atm和dna-pk抑制剂 |
| WO2019201283A1 (en) | 2018-04-20 | 2019-10-24 | Xrad Therapeutics, Inc. | Dual atm and dna-pk inhibitors for use in anti-tumor therapy |
| JP7436465B2 (ja) * | 2018-09-14 | 2024-02-21 | スゾウ、ザンロン、ファーマ、リミテッド | 毛細血管拡張性運動失調症変異（ＡＴＭ）キナーゼの選択的調節物質としての１－イソプロピル－３－メチル－８－（ピリジン－３－イル）－１，３－ジヒドロ－２Ｈ－イミダゾ［４，５－ｃ］シンノリン－２－オンおよびその使用 |
| MX391410B (es) * | 2018-09-30 | 2025-03-21 | Medshine Discovery Inc | Derivados de quinolino-pirrolidin-2-ona como inhibidores del gen mutado de ataxia telangiectasia (atm) y el uso de los mismos en el tratamiento de tumores sólidos. |
| WO2021022078A1 (en) * | 2019-07-30 | 2021-02-04 | Xrad Therapeutics, Inc. | Dual atm and dna-pk inhibitors for use in anti-tumor therapy |
| WO2021098734A1 (zh) * | 2019-11-19 | 2021-05-27 | 南京明德新药研发有限公司 | 作为atm抑制剂的有取代的喹啉吡咯酮类合物及其应用 |
| CN115380031A (zh) * | 2020-03-30 | 2022-11-22 | 南京明德新药研发有限公司 | 作为atm抑制剂的喹啉并吡咯烷-2-酮类化合物的晶型及其应用 |
| JP2023539715A (ja) | 2020-06-24 | 2023-09-19 | アストラゼネカ ユーケー リミテッド | 抗体－薬物コンジュゲートとａｔｍ阻害剤との組合わせ |
| ES2974742T3 (es) * | 2020-09-21 | 2024-07-01 | Wei Zhong | Compuestos de 1-(3,3-difluoropiperidin-4-il)-imidazo[4,5-c]quinolin-2-ona sustituidos con capacidad de penetración en la barrera hematoencefálica |
| EP3992191A1 (en) | 2020-11-03 | 2022-05-04 | Deutsches Krebsforschungszentrum | Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| US9370508B2 (en) * | 2007-02-20 | 2016-06-21 | Novartis Ag | Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| NZ596487A (en) * | 2009-06-04 | 2012-11-30 | Novartis Ag | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES AND THE USE THEREOF AS PI3K INHIBITORS |
| CN102372711B (zh) | 2010-08-18 | 2014-09-17 | 山东轩竹医药科技有限公司 | 咪唑并喹啉类PI3K和mTOR双重抑制剂 |
| CN102399218A (zh) | 2010-09-16 | 2012-04-04 | 和记黄埔医药（上海）有限公司 | 一类并合三杂环及其作为pi3k抑制剂的用途 |
| NO2714752T3 (https=) * | 2014-05-08 | 2018-04-21 |
-
2015
- 2015-11-05 GB GBGB1519568.8A patent/GB201519568D0/en not_active Ceased
-
2016
- 2016-11-02 CA CA3002717A patent/CA3002717A1/en not_active Abandoned
- 2016-11-02 JP JP2018522740A patent/JP2019501873A/ja not_active Withdrawn
- 2016-11-02 KR KR1020187015616A patent/KR20180073684A/ko not_active Withdrawn
- 2016-11-02 US US15/772,120 patent/US20180280377A1/en not_active Abandoned
- 2016-11-02 MX MX2018004954A patent/MX2018004954A/es unknown
- 2016-11-02 PE PE2018000610A patent/PE20181346A1/es unknown
- 2016-11-02 BR BR112018007811-5A patent/BR112018007811A2/en not_active Application Discontinuation
- 2016-11-02 CN CN201680063635.3A patent/CN108348515A/zh active Pending
- 2016-11-02 HK HK19100041.8A patent/HK1257677A1/zh unknown
- 2016-11-02 RU RU2018120492A patent/RU2018120492A/ru not_active Application Discontinuation
- 2016-11-02 WO PCT/EP2016/076416 patent/WO2017076898A1/en not_active Ceased
- 2016-11-02 CR CR20180308A patent/CR20180308A/es unknown
- 2016-11-02 EP EP16788723.1A patent/EP3370722A1/en not_active Withdrawn
- 2016-11-02 AU AU2016348620A patent/AU2016348620B2/en not_active Ceased
-
2018
- 2018-04-18 NI NI201800051A patent/NI201800051A/es unknown
- 2018-04-22 IL IL258828A patent/IL258828A/en unknown
- 2018-04-30 SV SV2018005680A patent/SV2018005680A/es unknown
- 2018-05-02 CL CL2018001171A patent/CL2018001171A1/es unknown
- 2018-05-03 DO DO2018000115A patent/DOP2018000115A/es unknown
- 2018-05-03 PH PH12018500957A patent/PH12018500957A1/en unknown
- 2018-05-09 CO CONC2018/0004933A patent/CO2018004933A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016348620A1 (en) | 2018-06-14 |
| SV2018005680A (es) | 2018-06-22 |
| GB201519568D0 (en) | 2015-12-23 |
| CN108348515A (zh) | 2018-07-31 |
| EP3370722A1 (en) | 2018-09-12 |
| PH12018500957A1 (en) | 2018-11-19 |
| RU2018120492A (ru) | 2019-12-05 |
| WO2017076898A1 (en) | 2017-05-11 |
| JP2019501873A (ja) | 2019-01-24 |
| KR20180073684A (ko) | 2018-07-02 |
| US20180280377A1 (en) | 2018-10-04 |
| CR20180308A (es) | 2018-10-02 |
| NI201800051A (es) | 2018-07-30 |
| CL2018001171A1 (es) | 2018-10-12 |
| RU2018120492A3 (https=) | 2020-01-30 |
| AU2016348620B2 (en) | 2019-05-02 |
| CA3002717A1 (en) | 2017-05-11 |
| CO2018004933A2 (es) | 2018-08-10 |
| HK1257677A1 (zh) | 2019-10-25 |
| BR112018007811A2 (en) | 2018-10-30 |
| MX2018004954A (es) | 2018-07-06 |
| DOP2018000115A (es) | 2018-06-30 |
| PE20181346A1 (es) | 2018-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258828A (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL248397B (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL258818A (en) | Imidazo[4,5-c]quinolin-2-ion compounds and their use in cancer treatment | |
| PL3303632T3 (pl) | Terapeutyczne i diagnostyczne sposoby stosowane w nowotworze | |
| GB201516504D0 (en) | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer | |
| ZA201803742B (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| PL3007694T3 (pl) | Pochodne pirazolopirydynowe do zastosowania w leczeniu nowotworu pęcherza moczowego | |
| ZA201807810B (en) | Adenosine derivatives for use in the treatment of cancer | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| IL258246B (en) | Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer | |
| GB201608227D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL266198A (en) | Liposomal formulation for use in cancer treatment | |
| PL3490560T3 (pl) | Niraparyb do stosowania w sposobie leczenia nowotworu prostaty | |
| DK3606926T3 (da) | Heteroaromatiske forbindelser anvendelige i terapi | |
| IL254228B (en) | Cell therapeutic agent for cancer treatment and combination therapy with same | |
| GB201604182D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| EP3380468B8 (en) | Bis-pyridazine compounds and their use in treating cancer | |
| HUE045185T2 (hu) | Új terápiás vegyület és terápiában történõ alkalmazása | |
| EP3439642A4 (en) | IMPROVEMENTS IN RADIOTHERAPY | |
| GB201615844D0 (en) | Agents for use in therapy | |
| HK1255487A1 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| ZA201508530B (en) | Pyrazolopyridine derivatives for use in the treatment of bladder cancer | |
| HK1259160A1 (en) | Bis-pyridazine compounds and their use in treating cancer | |
| TH1501007058A (th) | อนุพันธ์ไพราโซโลไพร์โรลิดีน และการใช้งานของพวกมันในการบำบัดโรค | |
| TH1401006251A (th) | 1h-ไพราโซโล[3,4-b]ไพริดีนและการนำไปใช้ในการรักษาโรค |